Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Activity in 2012

Actusnews 
0 0 24.01.13
Activity in 2012
 


(Unaudited data)



  • CUMULATIVE ACTIVITY AS OF THE END OF DECEMBER 2012




















































thousands of euros 2011 2012 Variation at current exchange rates Variation at constant exchange rates
France 292,181 325,900 +11.5% +11.5%
International : 231,034 240,394 +4.1% +2.4%
Incl. Europe excluding France 185,014 184,489 -0.3% -0.8%
Incl. North America 38,416 45,345 +18.0% +9.6%
Incl. Other countries 7,604 10,560 +38.9% +41.0%
Group Total 523,215 566,294 +8.2% +7.5%








































thousands of euros 2011 2012 Variation at current exchange rates Variation at constant exchange rates
Non-proprietary Homeopathic Medicines 265,636 292,025 +9.9% +9.6%
OTC Specialties 257,748 273,776 +6.2% +5.1%
Other -0,169 0,493    
Group Total 523,215 566,294 +8.2% +7.5%


  • QUARTERLY ACTIVITY IN 2012 (variation at current rate)























































































































































































































  1st Quarter 2nd Quarter 3rd Quarter 4th Quarter
thousands of euros 2011 2012 Var. 2011 2012 Var. 2011 2012 Var. 2011 2012 Var.
France 70,466 74,188 +5.3% 59,744 71,210 +19.2% 79,943 88,028 +10.1% 82,028 92,474 +12.7%
                         
International : 58,478 54,904 -6.1% 37,128 41,216 +11.0% 67,885 69,839 +2.9% 67,543 74,435 +10.2%
Incl. Europe excluding France 47,024 41,807 -11.1% 28,880 28,889 +0.0% 55,013 55,345 +0.6% 54,097 58,448 +8.0%
Incl. North America 9,566 10,285 +7.5% 6,113 9,861 +61.3% 11,077 11,136 +0.5% 11,660 14,063 +20.6%
Incl. Other countries 1,888 2,812 +48.9% 2,135 2,466 +15.5% 1,795 3,358 +87.1% 1,786 1,924 +7.7%
Group Total 128,944 129,092 +0.1% 96,872 112,426 +16.1% 147,828 157,867 +6.8% 149,571 166,909 +11.6%
 
  1st Quarter 2nd Quarter 3rd Quarter 4th Quarter
thousands of euros 2011 2012 Var. 2011 2012 Var. 2011 2012 Var. 2011 2012 Var.
Non-proprietary Homeopathic

Medicines		 69,371 73,427 +5.8% 62,414 70,206 +12.5% 63,246 69,959 +10.6% 70,605 78,433 +11.1%
OTC Specialties 59,417 55,576 -6.5% 34,499 42,007 +21.8% 84,645 87,811 +3.7% 79,187 88,382 +11.6%
Other 0,156 0,089   -0,041 0,213   -0,063 0,097   -0,221 0,094  
Group Total 128,944 129,092 +0.1% 96,872 112,426 +16.1% 147,828 157,867 +6.8% 149,571 166,909 +11.6%



FOURTH QUARTER HIGHLIGHTS



  • Sales revenue in the fourth quarter of 2012 grew by 11.6% (10.6% at constant exchange rates):

    • In France, sales of non-proprietary medicines increased by 16.3% due to price increases applied to some of them.

    • OTC specialties increased, especially in France, Poland, Russia and the US, particularly through the winter OTC specialties.



  • In the United States, the settlement agreement signed on March 6, 2012 which shall put an end to all current class action proceedings (with the exception of the claim relating to Children's Coldcalm®) obtained final approval of the San Diego Court in its judgment dated October 31, 2012. Appeals were filed against this judgment which admissibility is under consideration by the Court of Appeal.


  • On December 17, 2012, the company “Pierre Fabre SA” sold its shareholding in BOIRON (3,330,436 shares) to the benefit of some members of the BOIRON family group for 1,289,593 shares and of the company BOIRON itself for 2,040,843 shares within the frame of the applicable share buyback program. The shares acquired by the company BOIRON were cancelled on January 1, 2013 in accordance with the Board of Directors' decision dated December 19, 2012.


  • At December 31, 2012, the group's net cash position exceeded 90 million euros.

Operating income in 2012 is expected to increase significantly as compared to 2011.


Our next update: March 13, 2013, after the close of the stock market, publication of 2012 results.

Financial information manager: Philippe MONTANT

Contact for financial information: Véronique BOUSCAYROL

Investor relations: +33 (0) 4.78.45.63.43 - e-mail: [email protected]

ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA

The group's financial information is online at : www.boiron.com

Information réglementée
Communiqués au titre de l'obligation d'information permanente :

- Communiqué sur comptes, résultats, chiffres d'affaires
Communiqué intégral et original au format PDF :


http://www.actusnews.com/documents_communiques/ACTUS-0-30762-cp-boiron-240113.pdf

<!-- 90 -->

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free


<br/><p>Quelle: <a href="http://www.actusnews.com/" target="_blank" rel="nofollow">Actusnews</a></p>

Boiron S.A. Stock

€32.10
-1.530%
We can see a decrease in the price for Boiron S.A.. Compared to yesterday it has lost -€0.500 (-1.530%).

Show more
Like: 0
Share

Comments

Not a member yet? Sign up for free!